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ExpErimEntal modEl of C6 Brain 
tumors in athymiC rats
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Abstract – Malignant brain tumor experimental models tend to employ cells that are immunologically 
compatible with the receptor animal. In this study, we have proposed an experimental model of encephalic 
tumor development by injecting C6 cells into athymic Rowett rats, aiming at reaching a model which more 
closely resembles to the human glioma tumor. In our model, we observed micro-infiltration of tumor cell 
clusters in the vicinity of the main tumor mass, and of more distal isolated tumor cells immersed in normal 
encephalic parenchyma. This degree of infiltration is superior to that usually observed in other C6 models.
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modelo experimental de tumor cerebral C6 em ratos atímicos
Resumo – Modelos experimentais de tumores cerebrais malignos geralmente utilizam células imunologicamente 
compatíveis com o animal receptor. Neste estudo apresentamos um modelo experimental baseado na 
inoculação de células C6 em ratos atímicos Rowett, visando obter um tumor que se assemelhe mais àqueles 
observados nos seres humanos. Neste modelo observamos microinfiltração de ilhotas de células na periferia 
da massa tumoral principal e nas áreas mais distantes, células tumorais isoladas no tecido cerebral normal. 
este grau de infiltração é superior àquele observado em outros modelos utilizando as células C6.
PAlAvRAs-ChAve: tumor cerebral, células C6, modelo experimental, glioma.
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The need for therapeutic strategies for gliomas has led 
to the development of experimental models simulating 
the growth and invasive characteristics of these tumors. 
experimental models tend to employ cells that are immu-
nologically compatible with the receptor animal. one of 
the most classical multiform glioblastoma models is based 
on injecting C6 cells (murine glioma) into wistar rats. 
Recent studies have demonstrated that these cells 
induce a strong immunological response in wistar rats 
which, in turn, may compromise interpretation of the re-
sults in therapeutic tests. Another approach is based on 
using immunosuppressed animals. Immunosupressed (or 
athymic) rats are necessary when inoculating cell cultures 
derived from patient’s tumors. other models are either in-
compatible, or do not reproduce the invasive character-
istics of gliomas1-7.
The objective of the present work was to present the 
technique, along with clinical and pathological results, for 
an experimental glioma model by injecting murine glioma 
cells (C6) in athymic rats.
mEthod
Cell culture
C6 murine glioma cells were provided by the Cell and Mo-
lecular Therapy Center (NUCel) of the são Paulo Universi-
ty (UsP). Cells were cultured in dulbecco’s modified medium 
(dMeM, Gibco BRl, Gaithersburg, Md), supplemented with 10% 
fetal bovine serum (Cultilab, Campinas, sP, Brazil) and antibiot-
ics (penicillin 200 UI/ml and streptomycin, 100 mg/ml, Invit-
rogen, UsA), in 5% Co2 atmosphere, at 37oC. Upon reaching con-
fluence, the cultures were dissociated using trypsin/edTA 250 
mg% (Cultilab, Campinas, são Paulo) and resuspended in serum-
free dMeM. The cells were centrifuged, counted in a Neubauer 
chamber (optik labor, Germany) and suspended at 1x105 cells in 
4 ml of serum-free dMeM.
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Subcutaneous innoculation
Female Rowett rats, (n=2) weighing 140g, were provided by 
the Animal Facility of the University of são Paulo Chemistry In-
stitute. The animals were maintained in cages with individual 
ventilation systems (Tecniplast, Italy), with free access to water 
and autoclaved food. All animals were handled in accordance 
with the guidelines recommended by the UsP Medical school’s 
laboratory Animal Care Committee. Following antisepsis treat-
ment of the skin, using 70% ethanol, the C6 cell suspension (1x105 
cells) in 4 ml of serum-free dMeM was inoculated into the right 
flank of the animals. 
The animals were observed daily for 21 days. At the end of 
this period, the tumor mass of both rats measured 2.5 cm across 
their widest diameter. subsequently, the rats were sacrificed us-
ing a ketamine overdose (25 mg) and the tumor mass was surgi-
cally extracted using sterile techniques. The weight of the two 
masses was identical in both rats, namely 3.58g. These tumor 
masses were used to generate primary cultures and, repeating 
the culture process outlined, further aliquots of 1x105 C6 cells in 
4 ml of serum-free dMeM were prepared.
Intracerebral inoculation
Five female Rowett rats, weighing an average of 140g provid-
ed by the Animal Facility of the UsP Chemistry Institute, were 
anesthetized using ketamine (90 mg/kg) and positioned in a ste-
reotaxic device for small animals (Kopft, Germany). After an-
tisepsis of the skin covering the cranium using 70% ethanol, a 
median incision of approximately 1 cm was made and access to 
the cranial cavity was achieved by means of a right frontal trep-
anation, 2 mm in front of the coronal suture and 2 mm to the 
side of the sagittal suture (standard coordinates for brain tu-
mor models). This procedure was carried out using a mini elec-
tric drill (Bosch).
An aliquot (1x105) of C6 cells in 4 ml of serum-free dMeM 
was inoculated to a depth of 3 mm with a 25 ml hamilton syringe 
using the stereotaxic technique. Inoculation was performed 
slowly over a 5-minute period. The needle was left in position 
for 10 minutes to prevent from refluxing along the needle tra-
jectory. After removing the needle, trepanation was occluded 
using wax for bone (ethicon), and the skin was sutured using two 
separate 5-0 mononylon stitches (ethicon). Following the surgi-
cal procedure, the rat was placed back into the cage with free 
access to water and food.
The rats were examined daily to check for any changes in 
gait, suggestive of motor deficit, or secretion build-up in the 
periocular region. Three weeks later, despite slight signs of peri-
ocular secretion build-up and no motor deficit symptoms, the 
rats were sacrificed using a thionembutal overdose. Cardiac per-
fusion was performed with 100 ml phosphate buffer saline (PBs) 
and 80 ml of 4% paraformaldehyde, followed by extraction of 
the brains. The whole brains were fixed in 4% paraformalde-
hyde for one week, then sliced in coronal preparations of 1 cm 
of thickness, mounted in paraffin blocks, followed by prepara-
tion of 5 mm-thick serial sections. Relevant macroscopical slic-
es of the tumor, together with surrounding cerebral tissue, were 
mounted on microscope slides and stained with eosin-hematox-
ylin for histological analysis.
Figure. HE, 40x. Brain tumor transi-
tion area. No clear limit between tu-
mor mass and neighboring brain pa-
renchyma is observed. Numerous ba-
sophilic tumor cells clustering deep-
er in the brain parenchyma can be 
observed (arrows). The perivascular 
space is also infiltrated by tumor cells 
(arrowhead).
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rEsults
No peri-operatory deaths occurred and none of the 
rats developed evident infectious complications, suggest-
ing that basic asseptic care (asepsis of the skin and ster-
ilization of surgical materials) was sufficient in handling 
athymic Rowett rats for the purposes stated. 
Clinical assessment of the rats during the post-opera-
tive period revealed that the animals presented discrete 
periocular secretion build-up from the 17th day after in-
oculation. No motor deficits were manifest. 
Macroscopic analysis of the brain fragments demon-
strated a tumor mass, which was visible to the naked eye 
in 100% of the rats. The lesion spread to the cortical sur-
face at the inoculation point in all animals, displacing 
structures from the median line.
Analysis of the slides at lower magnification showed 
that the tumors took a predominantly spheroid configu-
ration, located at the right frontal lobe, compressing and 
infiltrating the adjacent structures.
higher magnification revealed that tumors were 
formed by polygonal-shaped cells with basophylic nuclei 
and eosinophyl cytoplasm. hemorrhagic necrosis in small 
clusters was presented in all cases. The brain-tumor inter-
face (Figure) demonstrated microscopic infiltration at the 
borders of the main lesion, where grouping of tumor cells 
were found beyond the edges of the main mass, even with 
some isolated tumor cells immersed in the cerebral paren-
chyma. This infiltration occurred not only in the cerebral 
parenchyma but also throughout the perivascular spac-
es. Infiltration of the leptomeningeal space was also ob-
served. There was little inflammatory response adjacent 
to the tumor lesions.
disCussion
Malignant brain gliomas, particularly glioblastomas 
have been the subject of intense study, mainly aiming at 
the discovery of more effective forms of treatment. The 
invasive pattern of gliomas and the migration of neoplas-
tic cells along encephalic tracts and perivascular space 
renders such tumors very difficult to reproduce in experi-
mental models. 
Brain tumor cell culture models minimize the inflam-
matory and angiogenic responses which gliomas trigger 
in human brain tissue1. Animal tumor models based on 
implantation of established cell lines complement studies 
carried out in cell cultures, allowing the in vivo study of 
tumor responses to various therapeutic strategies. In addi-
tion, animal models allow comparison between groups of 
control and treated rats harboring tumors with more ho-
mogeneous size and location characteristics2. The ability 
to achieve accurate cell counts and homogeneously grow-
ing tumors was demonstrated by the two subcutaneously 
inoculated rats in our experiment, since upon infection of 
the same number of cells (5x105), they developed tumors 
of identical weight.
one of the most classical multiform glioblastoma 
models is based on injecting C6 cells. These cells have 
been used in experimental models with sprague-dawley, 
long-evans and wistar rats, which are immunecompetent, 
therefore growth is under influence of the immune sys-
tem. C6 cells growth is strongly influenced by the breed 
of rat in which they are inoculated. Tumors formed in the 
sprague-dawley and long-evans breeds are encapsulated 
and have well-defined limits, resembling metastatic le-
sions3. Possibly the spheroid shape of the tumor masses 
represent more of a walling off and a degree of genetic 
incompatibility. however, when these cells are inoculat-
ed into the brain of wistar rats, they exhibit invasive and 
pleomorphic GBM characteristics, including sites of ne-
crosis and hemorrhage. other aspects observed in wistar 
rats include a high mitotic rate, cells forming palisades, 
and neovascularization4. These characteristics have led to 
the use of the C6/wistar model in experiments due to 
its similarity to the human GBM5. despite this similarity, 
other authors believe this model does not possess the 
same heterogeneity, immuno-histochemical characteris-
tics or invasive capacity of the GBM6.
In vivo evidence shows that when C6 cells are inocu-
lated into wistar rats, they trigger a host-graft incompat-
ibility immune response. when wistar rats were simul-
taneously inoculated into the brain and subcutaneously 
into the flank, 100% survival was observed, compared to 
11% survival when inoculated only into the brain. It was 
concluded that C6 cells inoculated subcutaneously induce 
a significant immune response in wistar rats, mimicking 
an anti-tumoral immune response while preventing this 
tumor from growing in brain tissue7. Interestingly, sponta-
neous regression after 70 days of stereotaxic inoculation 
of C6 cell spheroids into brains of immunocompetent and 
thymectomized sprague-dawley rats has reported8.
The exact origin of C6 cells remains unclear. some 
authors have reported that these cells in fact originated 
from wistar rats6, and were chemically induced in wistar-
Furth rats by exposure to N,N’-nitrosomethylureia9. other 
authors have described C6 cells as compatible with BdIX10 
and sprague-dawley rats11. More recent molecular studies 
have isolated the RTu haplotype from C6 cells, indicating 
that it is consistent with the allogenicity in wistar, BdIX, 
BdX and sprague-dawley rats12. some authors have stated 
that C6 cells are not genetically compatible with any rat 
breed, and hence the immune response represents a limi-
tation for the use of this model, specially if the compara-
tive index is survival7,13. In fact, this C6 model is considered 
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to be unsuitable for studying inflammatory changes ob-
served in human gliomas13.
The use of an athymic model is helpful when using a 
completely dissimilar human cell line in an animal model, 
therefore, athymic rats are more typically used in stud-
ies involving xenografts. To use an athymic animal for de-
veloping an animal model with a C6 cell derived from 
rat, as presented here, downregulates the inflammatory 
response which may enhance the invasive characteristics 
of the tumor. 
our findings are compatible with a low immune re-
sponse characterized by the near absence of inflammatory 
cells surrounding the tumor masses. The variable degree 
of an inflammatory response observed in other models is 
possibly evidence of immune incompatibility rather than 
the nature of a high grade glioma. The presence of an in-
tact immune system is more likely to the forming of more 
encircled lesions such as those described for sprague-
dawley and long-evans rat breeds. A morphometric study 
of C6 cell implants in rats has reported that the brain-tu-
mor interface was well defined in immunocompetent rats, 
when compared to New Zealand athymic rats14.
In our model, we observed micro-infiltration of tumor 
cell clusters in the vicinity of the main tumor mass, and 
of more distal isolated tumor cells immersed in normal 
encephalic parenchyma (Figure). This degree of infiltration 
is superior to that usually observed in other C6 models.
Notwithstanding results observed of tumor invasive be-
ing attributed to the low immunological response of Row-
ett rats, other complex interactions amongst tumor cells 
and brain structures should also be taken into account.
In conclusion, C6 cells have high infiltrative character-
istics when inoculated into athymic rats, resembling those 
observed in human GBM.
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